Journals / Anadolu Kardiyoloji Dergisi / 2006 / Cilt: 6 - Sayı: 3

Stabil angina pektorisli hastalarda NT-ProBNP'yi kullanarak koroner arter hastalığı ciddiyetini öngörebilir miyiz?

Can we predict the severity of coronary artery disease in patients with stable angina using NT-ProBNP?

Pages
235–238
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In patients with unimpaired regional diastolic function, NT-proBNP may be valuable to predict the presence of severe CAD in stable angina.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: We aimed to investigate the value of N-terminal pro-Brain Natriuretic Peptide (NT-proBNP) in combination with tissue Doppler imaging (TDI) to predict the presence of significant coronary artery (CAD) in patients with conventionally normal systolic and diastolic function .
📊
Key Findings & Data:Methods: Plasma NT-proBNP concentrations were measured in 87 patients who had been referred to coronary angiography with stable anginal symptoms, and preserved systolic and diastolic LV function in conventional echocardiography.
💡
Conclusion & Impact:In patients with unimpaired regional diastolic function, NT-proBNP may be valuable to predict the presence of severe CAD in stable angina.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: We aimed to investigate the value of N-terminal pro-Brain Natriuretic Peptide (NT-proBNP) in combination with tissue Doppler imaging (TDI) to predict the presence of significant coronary artery (CAD) in patients with conventionally normal systolic and diastolic function . Methods: Plasma NT-proBNP concentrations were measured in 87 patients who had been referred to coronary angiography with stable anginal symptoms, and preserved systolic and diastolic LV function in conventional echocardiography. Regional diastolic function was additionally assessed by TDI in all patients. Patients were then divided into 2 groups according to having normal or abnormal diastolic function with TDI. Group 1 had preserved diastolic function with conventional and TDI methods. Group 2 had conventionally normal function and abnormal regional function with TDI. Groups were divided into 2 subgroups according to the cut-off NT-proBNP value of 100pg/ml. Coronary artery disease was classified as 0 (absence of >70% diameter stenosis in any coronary artery), 1, 2 or 3 vessel disease (with lesions >70%). Results: The NT-proBNP levels were positively correlated with the number of coronary vessels involved. There was statistically significant difference between 0-2, 0-3, 1-3 vessels involvement, but no significant difference between 0-1, 1-2, 2-3 vessels involvement. In group 1 all patients with plasma NT-proBNP levels >100 pg/ml had severe CAD (p=0.003). But in group 2 only 60% of patients with NT-proBNP>100 pg/ml had severe CAD. Conclusion: In patients with stable angina who have normal systolic and diastolic function, NT-proBNP is useful to predict the angiographic severity of CAD. In patients with unimpaired regional diastolic function, NT-proBNP may be valuable to predict the presence of severe CAD in stable angina.

Özet

Amaç: Konvansiyonel olarak sistolik ve diyastolik fonksiyonları normal olan olgularda doku Doppler (TDI) tetkikinin sonuçlarına göre koroner arter hastalığı (KAH) mevcudiyetini öngörmede N-terminal Pro-Beyin Natriüretik Peptid'in (NT-proBNP) değerini araştırmayı amaçladık. Yöntemler: Koroner anjiyografi için başvuran stabil anginalı, sistolik fonksiyonu korunmuş ve konvansiyonel yöntemle normal diyastolik işleve sahip 87 hastada plazma NT-proBNP düzeyleri ölçüldü. Ayrıca bütün hastalarda doku Doppler (TDI) kullanılarak bölgesel diyastolik disfonksiyon araştırıldı. Hastalar TDI sonuçlarına göre iki gruba ayrıldı. Grup 1 konvansiyonel yöntemle ve TDI ile normal diyastolik fonksiyona sahipti. Grup 2 konvansiyonel olarak normal diyastolik fonksiyona sahipken TDI ile bölgesel diyastolik disfonksiyon tespit edilen hastaları kapsıyordu. Gruplar NT-proBNP “cut-off” değeri 100 pg/ml kabul edilerek kendi içinde ikiye ayrıldı. Bulgular: Plazma NT-proBNP seviyesi hastalıklı damar sayısı ile pozitif olarak korele bulundu. Plazma NT-ProBNP seviyeleri açısından 0-2, 0-3, 1-3 damar hastalığı arasında anlamlı fark bulundu, fakat 0-1, 1-2, 2-3 damar hastalığında anlamlı fark bulunmadı. Grup 1'de plazma NT-proBNP seviyeleri > 100 pg/ml bütün hastalarda ciddi koroner arter hastalığı (KAH) tespit edilirken (p=0.003) grup 2'de NT-proBNP değeri > 100 pg/ml olan hastaların %60'ında ciddi KAH tespit edildi. Sonuçlar: Stabil anginalı, sistolik ve diyastolik fonksiyonu korunmuş hastalarda NT-proBNP KAH ciddiyetini saptamada yararlıdır. Doku Doppler ile bölgesel diyastolik disfonksiyonu olan gruba kıyasla olmayanlarda NT-proBNP'nin KAH ciddiyetini öngörücü değeri daha fazladır.

🔖

Cite This Article

KÖSEOĞLU, M., ARIKAN, E., BAYATA, S., POSTACI, N., CEYLAN, Ö., YEŞİL, M. (2022). Stabil angina pektorisli hastalarda NT-ProBNP'yi kullanarak koroner arter hastalığı ciddiyetini öngörebilir miyiz?. Anadolu Kardiyoloji Dergisi, Cilt: 6 - Sayı: 3, 235–238. https://ajindex.com/articles/437266

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. McCullough PA, Omland T, Maisel AS. B-type natriuretic peptides: a diagnostic breakthrough for clinicians. Rev Cardiovasc Med 2003; 4: 72-80
  2. Sabatine MS, Morrow DA, de Lemos JA, Omland T, Desai MY, Tanasijevic M, et al. Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia. J Am Coll Cardiol 2004; 44: 1988-95
  3. Bibbins-Domingo K, Ansari M, Schiller NB. B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the Heart and Soul study. Circulation 2003; 108: 2987-92
  4. Omland T, Persson A, Ng L, O'Brien R, Karlsson T, Herlitz J, et al. N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation 2002; 106: 2913-8
  5. Uusimaa P, Tokola H, Ylitalo A, Vuolteenaho O, Ruskoaho H, Risteli J, et al. Anglo-Scandinavian Cardiac Outcomes Trial Investigators. Plasma B-type natriuretic peptide reflects left ventricular hypertrophy and diastolic function in hypertension. Int J Cardiol 2004; 97: 251-6
  6. Pruszczyk P, Kostrubiec M, Bochowicz A, Styczynski G, Szulc M, Kurzyna M, et al. N-terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism. Eur Respir J 2003; 22: 649-53
  7. Wozakowska-Kaplon B. Effect of sinus rhythm restoration on plasma brain natriuretic peptide in patients with atrial fibrillation. Am J Cardiol 2004; 93: 1555-8
  8. Cataliotti A, Malatino LS, Jougasaki M, Zoccali C, Castellino P, Giacone G, et al. Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling. Mayo Clin Proc 2001; 76: 1111-9
  9. Weber M, Dill T, Arnold R, Rau M, Ekinci O, Muller KD, et al. N-terminal B-type natriuretic peptide predicts extent of coronary artery disease and ischemia in patients with stable angina pectoris. Am Heart J 2004; 148: 612-20
  10. Kragelund C, Gronning B, Omland T, Kober L, Strande S, Steffensen R, et al. Is NT-proBNP a useful screening test for angiographic findings in patients with stable coronary disease? Am Heart J 2006; 151: 712.e1-712.e7
  11. C.F Mädler, N Payne, U Wilkenshoff, A Cohen, G.A Derumeaux, L.A Piérard for the MYDISE Study Investigators (Myocardial Doppler in Stress Echocardiography) Non-invasive diagnosis of coronary artery disease by quantitative stress echocardiography: optimal diagnostic models using off-line tissue Doppler in the MYDISE study. Eur Heart J 2003; 24: 1584-94
  12. Schnabel R